Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.100 | 0.727 | 11 | 2004 | 2018 | |||||||
|
0.763 | 0.240 | 22 | 19942598 | intron variant | A/G | snv | 0.23 |
|
Mental Disorders | 0.090 | 0.889 | 9 | 2004 | 2017 | |||||||
|
0.807 | 0.120 | 22 | 19965038 | 3 prime UTR variant | G/A | snv | 0.27 |
|
Mental Disorders | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||||
|
0.807 | 0.120 | 22 | 19965038 | 3 prime UTR variant | G/A | snv | 0.27 |
|
Pathological Conditions, Signs and Symptoms | 0.040 | 1.000 | 4 | 2013 | 2018 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 1.000 | 3 | 2010 | 2020 | |||||||
|
0.827 | 0.240 | 22 | 19962429 | 5 prime UTR variant | A/G | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.925 | 0.040 | 22 | 19940569 | intron variant | G/A;T | snv |
|
Mental Disorders | 0.020 | 0.500 | 2 | 2007 | 2009 | ||||||||
|
0.763 | 0.240 | 22 | 19942598 | intron variant | A/G | snv | 0.23 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.763 | 0.240 | 22 | 19942598 | intron variant | A/G | snv | 0.23 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.925 | 0.080 | 22 | 19962703 | synonymous variant | C/T | snv | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 22 | 19962703 | synonymous variant | C/T | snv | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.851 | 0.200 | 22 | 19962555 | missense variant | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.851 | 0.200 | 22 | 19962555 | missense variant | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.851 | 0.200 | 22 | 19962555 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.851 | 0.200 | 22 | 19962555 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Digestive System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.677 | 0.280 | 22 | 19969258 | 3 prime UTR variant | G/A | snv | 0.56 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 |